Dr. Shuqiang Yuan 袁庶强
Chief Physician
Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastrointestinal tumors, specializing in robot-assisted and laparoscopic minimally invasive surgery, stomach-preserving procedures, and neoadjuvant chemotherapy, targeted therapy, and immunotherapy for gastric cancer.
Dr. Yuan holds a medical doctorate from Sun Yat-sen University (2011) and completed visiting studies at MD Anderson Cancer Center (2009–2011). With over ten years of experience in abdominal tumor surgery and basic research, Dr. Yuan focuses on multidrug resistance reversal mechanisms and tumor cell energy metabolism. Dr. Yuan has led two National Natural Science Foundation projects and published over 30 SCI papers as first or corresponding author.
Professional roles
- Vice Chair, Gastrointestinal Tumor Branch, Guangdong Precision Medicine Application Society
- Youth Member, Gastric Cancer Professional Committee, Guangdong Anti-Cancer Association
- Member, Gastrointestinal Surgery Branch, Guangdong Medical Association
- Member, Minimally Invasive Surgery Professional Committee, Guangdong Clinical Medical Society
Name order: in Chinese the family name comes first (Yuan Shuqiang). Papers usually list the name as Shuqiang Yuan or Yuan S.
Selected publications
77 papers on PubMed matched by name and affiliation; 20 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Clin Oncol, 2026 (senior author): Reply to: Is the Extent of Lymph Node Dissection a Confounder in Perioperative Immunotherapy?. PubMed 42842866
- J Clin Oncol, 2026 (senior author): Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial. PubMed 42085639
- Cancer Cell, 2026 (senior author): Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer. PubMed 41720086
- Biomolecules, 2024 (senior author): Application of Spatial Transcriptomics in Digestive System Tumors. PubMed 39858416
- Aging Med (Milton), 2024 (senior author): The efficacy of neoadjuvant immunotherapy combined with chemotherapy in elderly patients with gastric cancer: A subgroup analysis of the NEOSUMMIT-01 study. PubMed 39234202
- Lab Invest, 2024 (senior author): Overexpression of COX7A1 Promotes the Resistance of Gastric Cancer to Oxaliplatin and Weakens the Efficacy of Immunotherapy. PubMed 38830579
- Eur J Med Res, 2024 (senior author): Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function. PubMed 38494472
- Nat Med, 2024 (first author): Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. PubMed 38191616
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion